Our strength

Aid’ARC has been providing services in Clinical Research for 20 years. The company was founded by Isabelle GAUDIN, who leds the company since its creation.

Today Aid’ARC brings together a team of 3 Senior Clinical Research Consultants, very dynamic and highly adaptable. The team has a high scientific level, a good knowledge of the hospital world and experience of complex clinical studies. It has the ability to be very responsive to the needs of the Pharmaceutical Industry and its partners.

Each Consultant works independently like a Freelance CRA, in direct connexion with the costumer.

Aid’ARC guarantees a quality service, rigorous, in meeting the time requirements.
The services are carried out in accordance with the procedures of the Promotor and in total confidentiality.

Our experience

Since the creation of Aid’ARC, our team has worked on more than 160 clinical studies, including numerous complex studies. This accumulated experience allows us today to respond to all missions with automatisms of quality and perfection.

  1. Phases :
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Others*

*: Compassionate Use Program, Post Marketing Study, Observational study, Medico-economic study, Pharmaco Epidemiology Investigation, Medico economic and Quality of life study, Feasibility study

2. Studies performed in Hospital or outside the hospital :

  • Studies performed at the Hospital
  • Outside the hospital

3. Activity :

  • CRA
  • Study-Coordinator
  • Lead CRA

4. Therapeutics Areas :

Detail below

Number of studies : 1

Phase : IV

Indications:

  • Allergic rhinitis

Number of studies : 25

Phase : III

Indications:

  • Arterial hypertension
  • Myocardial Infarction
  • Instable Angina
  • Lower Limb Arteriopathy
  • Transitional Ischemic Failure
  • Interventional Cardiology
  • Hypercholestérolémia
  • Inferior Limbs Arteriopathy
  • Infectius Endocarditis
  • Heart Failure
  • Heart failure with central sleep apnea
  • Cardiovascular high risk and hemodialysis
  • Acute coronary syndrome

Number of studies : 3

Phase : III, IV

Indications:

  • Deep vein thrombosis
  • Pulmonary embolisis

Number of studies : 3

Phase : IV

Indications:

  • Total Hip Prosthesis
  • Total knee Prosthesis
  • Knee surgery

Number of studies : 2

Phase : I, II

Indications:

  • Psoriasis
  • Scleroderma

Number of studies : 6

Phase : III, Etude Post-marketing

Indications:

  • Diabete
  • Diabetes / Children
  • Growth disturbance / Children and Adolescents

Number of studies : 10

Phase : II, III, IV, Etude rétrospective, Enquête Pharmaco-épidémiologique

Indications:

  • Dyslipaemia
  • Dyspepsia
  • Gastro-Hepatology
  • Gastroesophageal reflux
  • Crohn’s disease
  • Crohn’s disease and Ulcerative colitis
  • Colonoscopy

Number of studies : 1

Phase : II

Indications:

  • Sarcopenia

Number of studies : 3

Phase : IV

Indications:

  • Contraception with intra-uterine contraceptive device
  • Menopausis
  • Polycystic Ovary Syndrome

Number of studies : 1

Phase : III

Indications:

  • Idiopathic thrombocytopenic purpura

Number of studies : 16

Phase : I sans BID, II, III, IIIb, IV, ATU

Indications:

  • Aspergillosis, Candidosis, AIDS / HIV, Leukemia, Renal transplant transplantation rénale
  • Cystic Fibrosis (children, young adults)
  • Hepatitis C Virus Infection
  • Chronic Hepatitis C Virus Infection
  • Hepatitis C Virus Infection / Depression
  • Nosocomial pneumonia Gram +
  • Flu
  • Acute maxillary sinusitis
  • Varicella-Zoster Virus / autologous haematopoietic stem cell transplant
  • Varicella-Zoster Virus / haematologic malignancies
  • Vaccination study / Varicella-Zoster Virus

Number of studies : 11

Phase : I sans BID, III, IV

Indications:

  • Cerebrovascular accident
  • Aneurysm (Neurovascular)
  • Dépression
  • Back Pain (Neuromodulation)
  • Dystonia (neuromodulation)
  • Epilepsia
  • Parkinson Disease (neuromodulation)
  • Failed Back Surgery Syndrome(neuromodulation)
  • Sleep Disorder

Number of studies : 15

Phase :

III, Compassionate Use Program, Medico economic and Quality of life study, Observational study, Feasibility study

Indications:

  • Haemodialysis and cardiovascular disease
  • Renal Transplantation
  • Chronic Renal Insufficiency
  • Renal Insufficiency
  • Dialyse

Number of studies : 32

Phase :

I, II, III, IV

Pharmaco epidemio Investigation,

Epidemiology study,

Observationnal Study

Indications:

  • Breast Cancer
  • Colorectal Cancer
  • Colorectal Cancer with hepatectomy
  • Prostate Cancer
  • Lung Cancer (Non Small Cell Lung Cancer)
  • Pancreas Cancer
  • Cancer with anaemia
  • squamous cell carcinoma of head and neck
  • Metastatic cutaneous melanoma
  • Solid tumor or malignant Haemopathy

Number of studies : 4

Phase : II, III

Indications:

  • Hodgkin’s Lymphoma
  • Leukemia
  • Multiple myeloma

Number of studies : 3

Phase :

III, IV

Observationnal Study

Indications:

  • Glaucoma
  • Myopia
  • Diabetic macular edema

Number of studies : 5

Phase : III, IV, PMS

Indications:

  • Vaccine
  • Asthma
  • Diarrhea
  • Infant milk (cons skin manifestation)
  • Growth Disturbance

Number of studies : 17

Phase : III, IIIb, IV

Indications:

  • Acute Pneumopathy
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Uncontrolled Asthma
  • Bronchiolitis (RVS)
  • Uncontrolled Asthma and elevated blood Eosinophils
  • Acute community acquired pneumonia

Number of studies : 2

Phase : IV

Indications:

  • Dépression
  • Adaptation disorders with anxiety

Number of studies : 10

Phase :

II, III, IV

Pharmaco epidemio Investigation, Observationnal Study

Indications:

  • Rheumatoid arthritis
  • Vertebral Fracture
  • Shin Fracture
  • Osteoporosis
  • Rheumatoid polyarthritis
  • lumbosacral radiculopathy
  • Rheumatoid arthritis / Rheumatoid spondylitis

Medical Devices

Number of studies : 5

Phase : III, PMS

Indications:

  • Interventional Cardiology
  • Heart failure with central sleep apnea
  • Myocardial Infarction
  • Biprothesis aortic valve

Number of studies : 1

Phase : IV

Indications:

  • Contraception with intra-uterine contraceptive device

Number of studies : 1

Phase : I

Indications:

  • Cystic Fibrosis (children, young adults) / nebulizers

Number of studies : 6

Phase : PMS

Indications:

  • Failed Back Pain Surgery Syndrome
  • Back Pain
  • Parkinson disease

Number of studies : 1

Phase : PMS

Indications:

  • Aneurysm

Aid’ARC has been providing services in Clinical Research for 20 years

Additional experiences
  • • eCRF : Birt portal, Clincase, CSOnline, Datatrak, e-n@ble, EDC, Focus-Inova, iMedidata, Inform, Lincoln, MARVIN, Oracle, Projection, RDC, Castor, Trial Master, …
  • Internal Audits, external Audits and ANSM, FDA and MoH Inspections.